SLU-PP-915: dosing and an honest frame
> Updated:
Calculate the SLU-PP-915 dose
Enter your dose and diluent volume for SLU-PP-915 — the calculator will do the rest.
Human dosing
| Period / condition | Dose | Escalation |
|---|---|---|
| Start (oral) | 1 mg per day | Starting dose |
| Titration | 1–2 mg per day | Increase if needed |
| Upper reference in this schedule | up to 2–3 mg per day (may be split into 2 doses) | Maximum in this schedule |
Practical dosing and effect details
In Billon and colleagues' study (Journal of Pharmacology and Experimental Therapeutics, 2025/2026), SLU-PP-915 was given to mice orally, and its effect on running endurance turned out comparable to injectable SLU-PP-332 given intraperitoneally. The authors also showed the effect is stronger combined with exercise training rather than acting on its own. The data come from mice only.
That is exactly why the dosage on this page is expressed in oral milligrams per day (1-3 mg) rather than injection micrograms the way SLU-PP-332's page is: a different route means a different dose unit.
The upper range on this page (2-3 mg) is split into 2 doses for a reason: an oral dose less reliably holds a steady compound level for as long as a subcutaneous one does, so a single large dose is avoided here.
This is reference information for planning a research protocol, not a medical recommendation and not instructions for self-administration.
How to reconstitute
An example reconstitution for convenient dosing. The exact ratios depend on your vial. For research reference only — not medical guidance.
- 1Add the diluentUse bacteriostatic water. Example: 2 ml into a 10 mg vial.SLU-PP-91510 mg+ 2 mlDiluent
- 2Get the concentrationExample: 10 mg in 2 ml =SLU-PP-9155 mg/ml(5,000 mcg/ml)
- 3Work out the volume per doseFor example, for a 2.5 mg dose:2.5 mg = 0.5 ml= 50 u. (U-100)
This is only an example calculation. You can use a different diluent volume — plug your own numbers into the calculator. Open calculator →
Research protocols
SLU-PP-915: reference regimens
Controlled data on this compound are limited.
SLU-PP-915 is an orally active ERR agonist (an "exercise mimetic") that is taken by mouth in studies; unlike SLU-PP-332 it does not require injection.
SLU-PP-915 dosage actually answers a different question than SLU-PP-332's: not vial concentration, but how many oral milligrams per day, since the route of administration here is different.
More scientific background in the SLU-PP-915 monograph
Notes and safety
- • SLU-PP-915 is a research peptide. Human safety and efficacy data are limited.
- • The regimens shown are based on publications and research protocols, not clinical recommendations.
- • Individual reactions may vary. Published protocols typically start dosing at the lower end of the reported range.
- • Not recommended for use with chronic illness, pregnancy, or breastfeeding.
- • This information is for educational purposes and is not medical advice.
SLU-PP-915